close video
Get flash to see this player
insider - College of Medicine News Resource - University of Florida

Archive for 2015



A sheriff and a doctor team up to map childhood trauma

By • Mar 12th, 2015 • Category: Faculty in the News, Obstetrics and Gynecology, Pathology, Immunology, and Laboratory Medicine

UF Health pathologist Nancy S. Hardt, M.D., teamed with Alachua County Sheriff Sadie Darnell to improve the health and welfare of Gainesville residents living in a “hotspot” of poverty, child abuse and domestic violence.

A one-two vaccine punch could leave brain tumors vulnerable to the immune system

By • Mar 11th, 2015 • Category: From the Lab, Neurosurgery

A combination of a common vaccine and a specialized tumor vaccine could help patients with brain tumors live twice as long, according to research from Duke Cancer Institute and University of Florida Health.

Genetics breakthrough by group that includes University of Florida expert will boost diabetes research

By • Mar 10th, 2015 • Category: From the Lab, Pathology, Immunology, and Laboratory Medicine

A research group that includes a University of Florida genetics expert has located and narrowed down the number of genes that play a role in Type 1 diabetes.

Brain Awareness Week at University of Florida features lecture, student events

By • Mar 10th, 2015 • Category: Event, Neuroscience

The University of Florida will host several events for Brain Awareness Week, a worldwide event that aims to increase public awareness about the progress and benefits of brain research.

UF anesthesiologist honored for advancing acute pain care

By • Mar 10th, 2015 • Category: Anesthesiology, Awards, Faculty Recognition

An anesthesiologist at the University of Florida has recently received national recognition for his efforts in advancing research and education related to acute pain care.

Alumni Portrait: Jonathon Cohen, M.D. ‘07

By • Mar 10th, 2015 • Category: Anatomy and Cell Biology, Guest Column, Medicine

Jonathon Cohen, M.D. ’07, is pioneering clinical trials to develop targeted lymphoma treatments with fewer side effects and promising results.